JMERC
Owner
Janbazan Medical and Engineering Research Center (JMERC) is the owner of IJWPH.
0.4
Cite Score
SJR: 0.114 / SNIP: 0.090
Volume 16, Issue 1 (2024)
Iran J War Public Health 2024, 16(1): 75-79 |
Back to browse issues page
Article Type:
Subject:
History
Received: 2023/12/27 | Accepted: 2024/04/4 | Published: 2024/04/10
Received: 2023/12/27 | Accepted: 2024/04/4 | Published: 2024/04/10
How to cite this article
Sherhan A. A Comparison of the Effect of Multiple Inhalers Compared to Single Inhalers Salbutamol and Steroid on Patients with Asthma. Iran J War Public Health 2024; 16 (1) :75-79
URL: http://ijwph.ir/article-1-1426-en.html
URL: http://ijwph.ir/article-1-1426-en.html
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rights and permissions
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Authors
A.A. Sherhan *
Department of Medicine, Basrah Medical College, University Basrah, Basrah, Iraq
Abstract (520 Views)
Aims: In chronic persistent bronchial asthma, the combination of inhaled long-acting B2-agonists with inhaled steroids has long been used to reduce hospital admissions and improve quality of life, as opposed to using either medication alone. This study aimed to determine whether this type of inhaler therapy for patients with chronic asthma reduces symptoms, decreases the need for hospital admissions, improves the quality of life, and whether a high-dose combination is superior to a low dose in managing patients.
Materials & Methods: In this prospective descriptive cross-sectional study, 207 patients with chronic persistent bronchial asthma, using various inhalers, were randomly enrolled, of whom 120 cases (58.0%) were female and 87 cases (42.0%) were male, with ages ranging from 16 to 75 and a mean age of 45.59±14.67 years. The study assessed the type and dose of inhalers used, control over asthma symptoms, hospital admission rates, inhaler adherence, confidence in treatment, and pulmonary function test parameters (FEV1, FVC, and PEFR) while patients used their prescribed inhalers.
Findings: We found a statistically significant difference in FEV1/FVC between patients using single inhalers and those using combined inhaler therapy for chronic persistent asthma (p=0.005). However, there was no significant difference between the types of combined inhaler therapies (p=0.12). Age had no statistically significant effect in either comparison (p=0.85, 0.47, respectively).
Conclusions: Combined inhaler therapy for patients with persistent asthma is preferred by patients and shows superior efficacy compared to using either medication alone. Age does not significantly influence treatment response or patient preference.
Materials & Methods: In this prospective descriptive cross-sectional study, 207 patients with chronic persistent bronchial asthma, using various inhalers, were randomly enrolled, of whom 120 cases (58.0%) were female and 87 cases (42.0%) were male, with ages ranging from 16 to 75 and a mean age of 45.59±14.67 years. The study assessed the type and dose of inhalers used, control over asthma symptoms, hospital admission rates, inhaler adherence, confidence in treatment, and pulmonary function test parameters (FEV1, FVC, and PEFR) while patients used their prescribed inhalers.
Findings: We found a statistically significant difference in FEV1/FVC between patients using single inhalers and those using combined inhaler therapy for chronic persistent asthma (p=0.005). However, there was no significant difference between the types of combined inhaler therapies (p=0.12). Age had no statistically significant effect in either comparison (p=0.85, 0.47, respectively).
Conclusions: Combined inhaler therapy for patients with persistent asthma is preferred by patients and shows superior efficacy compared to using either medication alone. Age does not significantly influence treatment response or patient preference.
References
1. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008;31(1):143-78. [Link] [DOI:10.1183/09031936.00138707]
2. Global Initiative for Asthma (GINA). Global burden of asthma report. Fontana: Global Initiative for Asthma; 2009. [Link]
3. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. Fontana: Global Initiative for Asthma; 2016. p. 50-63. [Link]
4. Nigro SC, Sobieraj DM. Budesonide/glycopyrrolate/formoterol fumarate co-suspension metered dose inhaler: A triple therapy for the treatment of chronic obstructive pulmonary disease. Ann Pharmacother. 2022;56(5):582-91. [Link] [DOI:10.1177/10600280211038353]
5. Kelly HW, Sternberg AL, Lescher R, Fuhlbrigge AL, Williams P, Zeiger RS, et al. Effect of inhaled glucocorticoids in childhood on adult height. N Engl J Med. 2012;367(10):904-12. [Link] [DOI:10.1056/NEJMoa1203229]
6. Kew KM, Karner C, Mindus SM, Ferrara G. Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children. Cochrane Database Syst Rev. 2013;(12):CD009019. [Link] [DOI:10.1002/14651858.CD009019.pub2]
7. Melani AS. Inhalation therapy training: A priority challenge for the physician. Acta Biomed. 2007;78(3):233-45. [Link]
8. Nair SJ, Daigle KL, DeCuir P, Lapin CD, Schramm CM. The influence of pulmonary function testing on the management of asthma in children. J Pediatr. 2005;147(6):797-801. [Link] [DOI:10.1016/j.jpeds.2005.07.023]
9. Sestini P, Cappiello V, Aliani M, Martucci P, Sena A, Vaghi A, et al. Prescription bias and factors associated with improper use of inhalers. J Aerosol Med. 2006;19(2):127-36. [Link] [DOI:10.1089/jam.2006.19.127]
10. Adams RJ, Smith BJ, Ruffin RE. Patient preference for autonomy in decision making in asthma management. Thorax. 2001;56(2):126-32. [Link] [DOI:10.1136/thorax.56.2.126]
11. Papi A, Haughney J, Virchow JC, Roche N, Palkonen S, Price D. Inhaler devices for asthma: A call for action in a neglected field. Eur Respir J. 2011;37(5):982-5. [Link] [DOI:10.1183/09031936.00150910]
12. Chrystyn H, Price D. Not all asthma inhalers are the same: Factors to consider when prescribing an inhaler. Prim Care Respir J. 2009;18(4):243-9. [Link] [DOI:10.4104/pcrj.2009.00029]
13. Haughney J, Price D, Barnes NC, Virchow C, Roche N, Chrystyn H. Choosing inhaler devices for people with asthma: Current knowledge and research needs. Respir Med. 2010;104(9):1237-45. [Link] [DOI:10.1016/j.rmed.2010.04.012]
14. Haughney J, Price D, Kaplan A, Chrystyn H, Horne R, May N, et al. Achieving asthma control in practice: Understanding the reasons for poor control. Respir Med. 2008;102(12):1681-93. [Link] [DOI:10.1016/j.rmed.2008.08.003]
15. Melani AS, Zanchetta D, Barbato N, Sestini P, Cinti C, Canessa PA, et al. Inhalation technique and variables associated with misuse of conventional metered-dose inhaler and newer dry powder inhaler inexperienced adults. Ann Allergy Asthma Immunol. 2004;93(5):439-46. [Link] [DOI:10.1016/S1081-1206(10)61410-X]
16. Penman ID, Ralston SH, Strachan MWJ, Hobson R, editors. Davidson's principles and practice of medicine. Amsterdam: Elsevier; 2022. p. 669-72. [Link]
17. Rafi MA, Tahmin CI, Tashrik S, Bonna AS, Jannat F, Mily SJ, et al. Adherence to inhalers and associated factors among adult asthma patients: An outpatient-based study in a tertiary hospital of Rajshahi, Bangladesh. Asthma Res Pract. 2022;8(1):1. [Link] [DOI:10.1186/s40733-022-00083-7]
18. Bond K, Coyle D, O'Gorman K, Coyle K, Spooner C, Lemière C, et al. Long-acting beta2-agonist and inhaled corticosteroid combination therapy for adult persistent asthma: Systematic review of clinical outcomes and economic evaluation. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2009. [Link]
19. Patel S, Padh H, Bhavsar C. MANOVA over ANOVA- A better objective in bioequivalence study. IJPSR. 2013;4(5):1874-1881. [Link]
20. Melani AS, Bonavia M, Cilenti V, Cinti C, Lodi M, Martucci P, et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med. 2011;105(6):930-8. [Link] [DOI:10.1016/j.rmed.2011.01.005]
21. Mohammed A, Khalaf H, Jamal Kamal B, Ali Kamal M. Prevalence of Asthma control in adult patients in Kirkuk city. Medical Journal of Babylon. 2024;20(1):53-57. [Link] [DOI:10.4103/MJBL.MJBL_363_22]
22. Ho SF, Omahony MS, Steward JA, Breay P, Burr ML. Inhaler technique in the older people in the community. Age Ageing. 2004;33(2):185-8. [Link] [DOI:10.1093/ageing/afh062]
23. Basheti IA, Armour CL, Bosnic-Anticevich SZ, Reddel HK. Evaluation of a novel educational strategy, including inhaler-based reminder labels, to improve asthma inhaler technique. Patient Educ Couns. 2008;72(1):26-33. [Link] [DOI:10.1016/j.pec.2008.01.014]
24. Kim SH, Kwak HJ, Kim TB, Chang YS, Jeong JW, Kim CW, et al. Inappropriate techniques used by internal medicine residents with three kinds of inhalers (a metered dose inhaler, Diskus, and Turbuhaler): Changes after a single teaching session. J Asthma. 2009;46(9):944-50. [Link] [DOI:10.3109/02770900903229701]
25. Chrystyn H, Price D. Not all asthma inhalers are the same: factors to consider when prescribing an inhaler. Prim Care Respir J. 2009;18(4):243-9. [Link] [DOI:10.4104/pcrj.2009.00029]